Discover research programs and initiatives that seek to inform prevention, diagnosis, and treatment for today’s major health challenges and conditions.
NHLBI-supported research has contributed to heart failure treatments using breakthrough therapies.
A cloud-based ecosystem with data and analytic capabilities to advance research on heart, lung, blood, and sleep diseases, disorders, and conditions.
CEAL is helping communities hardest hit by COVID-19. Learn more about CEAL and its programs.
Cholesterol is a waxy, fat-like substance the body needs for good health but in the right amounts. Unhealthy levels of cholesterol can lead to heart and blood vessel diseases.
Peripheral artery disease, or PAD, is a condition in which a sticky substance called plaque builds up in the arteries that carry blood away from the heart to other parts of the body.
Idiopathic pulmonary fibrosis (IPF) is a serious long-term disease that happens when the tissue surrounding the air sacs, or alveoli, in the lungs becomes thick and stiff for unknown reasons.
Overweight and obesity are chronic conditions that raise the risk of serious health problems, including heart disease and diabetes.
Sleep apnea is a common condition in which your breathing stops and restarts many times while you sleep. This can prevent your body from getting enough oxygen.
Acute Respiratory Distress Syndrome (ARDS) is a serious lung condition that causes low blood oxygen levels.
The NHLBI has materials for patients and health professionals on many health topics, such as asthma, heart disease, and sickle cell disease.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.